Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations

Documenti analoghi

• Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
  di: Wadhwani, Meenakshi, et al.
  Pubblicazione: (2016)
• The backlash against bioequivalence and the interchangeability of brand-name and generic drugs
  di: Kesselheim, Aaron S.
  Pubblicazione: (2011)
• Bioequivalence of generic and branded amoxicillin capsules in healthy human volunteers
  di: Pathak, Priyanka, et al.
  Pubblicazione: (2017)
• Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers
  di: Del Tacca, Mario, et al.
  Pubblicazione: (2009)
• Evaluating the bioequivalence of levetiracetam brand and generic oral tablets available in the Saudi market in vivo
  di: Danah ALRabeeah, et al.
  Pubblicazione: (2023-10-01)